- Julius D. NIDA's naltrexone research program. In: Julius D, Renault P, eds. Narcotic antagonists: naltrexone, NIDA research monograph no 9. Rockville, MD: National Institute of Drug Abuse, 1976:5-11.
- National Research Council Committee on Clinical Evaluation of Narcotic Antagonists. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Arch Gen Psychiatry 1978;35:335-40.
- Tennant FS, Rawson RA, Cohen AJ, Mann A. Clinical experience with naltrexone in suburban opioid addicts. J Clin Psychiatry 1984;45:42-5.
- San L, Pomarol G, Peri JM, Olle JM, Cami J. Follow-up after six-month maintenance period on naltrexone versus placebo in heroin addicts. Br J Addict 1991;86:983-90.
- Anton RE, Hogan I, Jalali B, Riordan CE, Kleber HD. Multiple family therapy and naltrexone in the treatment of opiate-dependence. Drug Alcohol Depend 1981;8:157-68.
- Bell JR, Young MR, Masterman SC, Morris A, Mattick RP, Bammer G. A pilot study of naltrexoneaccelerated detoxification in opioid dependence. Med J Aust 1999:171:26-30.
- Callahan EJ, Rawson RA, McCleave B. The treatment of heroin addiction: naltrexone alone and with behaviour therapy. Int J Addict 1980:15;795-807.
- Chan KY. The Singapore naltrexone community-based project for heroin addicts compared with drugfree community-based program: the first cohort. J Clin Forensic Med 1996;3:87-92.
- Garcia-Alonso F, GutierrazM, San L, et al. A multicentre study to introduce naltrexone for opiatedependence in Spain. Drug Alcohol Depend 1989;23:117-21.
- Freedman RR, Czertko G. A comparison of thrice weekly LAAM and daily methadone in employed heroin addicts. Drug Alcohol Depend 1981;8: 215-22.
- Ball JC, Ross A, eds. The effectiveness of methadone maintenance treatment: patients, programs, services, and outcome. New York: Springer-Verlag, 1991.
- Havassy B, Hall S. Efficacy of urine monitoring in methadone maintenance. Am J Psychiatry 1981;99: 1497-500.
- Schwartz B, Layderdale RM, Montgomery ML, Burch EA, Gallant DD. Immediate versus delayed feedback on urinalysis reports for methadone maintenance patients. Addict Behav 1987;12:293-5.
- ThomasM, Kaunders F, Harris M, Cooperstein J, Hough G, Resnick R. Clinical experiences with naltrexone in 370 detoxified addicts. In: Julius D, Renault P, eds. Narcotic antagonists: naltrexone, NIDA research monograph no. 9. Rockville, MD: National Institute of Drug Abuse, 1976: 88-92.
- Azrin NH, Sisson RW, Meyers R, Godley M. Alcoholism treatment by disulfiram and community reinforcement therapy. J Behav Ther Exp Psychiatr 1982;13:105-12.
- Lerner AG, Sigal M, Gelkopf M. Naltrexone abuse and risk of suicide. J Nerv Ment Dis 1993:181:706-7.
- Miotto K, McCann MJ, Rawson RA, et al. Overdose, suicide attempts and death among a cohort of naltrexone-treated opiod addicts. Drug Alcohol Depend 1997:45 :131-4.
- Swensen G. Monograph: 1998 overview of opioid related deaths in WA Jan-August 1997. Western Australia: WA Drug Abuse Strategy Office, 1998.
- Western Australia Taskforce on Drug Abuse. Protecting the community, report of the Taskforce on Drug Abuse. Perth, WA: Frank Daniels Pty Ltd, 1995.
Drug and Alcohol Review
Volume 19, 2000 - Issue 1